CN Patent

CN112888427A — 对乙酰氨基酚液体混悬液

Assigned to Haleon CH SARL · Expires 2021-06-01 · 5y expired

What this patent protects

本发明涉及适合用于口服施用的药物液体混悬液。更具体地，本发明涉及含有对乙酰氨基酚的药物液体混悬液，其中所述混悬液用具有小于或等于10µm的d50和小于或等于35µm的d90的对乙酰氨基酚颗粒配制，使得在长期储存过程中减少褐变变色。

USPTO Abstract

本发明涉及适合用于口服施用的药物液体混悬液。更具体地，本发明涉及含有对乙酰氨基酚的药物液体混悬液，其中所述混悬液用具有小于或等于10µm的d50和小于或等于35µm的d90的对乙酰氨基酚颗粒配制，使得在长期储存过程中减少褐变变色。

Drugs covered by this patent

Patent Metadata

Patent number
CN112888427A
Jurisdiction
CN
Classification
—
Expires
2021-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Haleon CH SARL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.